Microbiota Enrichment Associated with PD-1 Response

Studies have shown that the gut microbiome may influence antitumor immune response via innate and adaptive immunity, and preclinical research has highlighted the key role of the gut microbiota in mediating tumor response to chemotherapy and PD-L1, PD-1, or CTLA-4 ICIs.